Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia.

导出 LinkOut

翻译打印收藏纠错

作者： Fahad,Al Aql ^[1] ; Sami,Al-Hajjar ^[2] ; Latifa,Bin Mahmoud ^[1] ; Saleh,Al-Alaiyan ^[3] ; Haysam,Tufenkji ^[4] ; Ibrahim,Bin-Hussain ^[2] ; Sameh,Abuzaid ^[3] ; Vetha,Peter ^[1]

作者单位： Ministry of Health (MOH), Saudi Arabia. ^[1] National Immunization Technical Advisory Group (NITAG), Saudi Arabia. ^[2] Saudi Neonatology Society (SNS), Saudi Arabia. ^[3] Saudi Pediatrics Infectious Diseases Society (SPIDS), Saudi Arabia. ^[4]

关键词 Guidelines LRTI Palivizumab Prematurity RSV Saudi

DOI 10.1016/j.ijpam.2015.11.005

PMID 30805466

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

International journal of pediatrics & adolescent medicine

2016年3卷1期

38-42页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia.

International journal of pediatrics & adolescent medicine

相似文献

International journal of pediatrics & adolescent medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia.

International journal of pediatrics & adolescent medicine

相似文献

International journal of pediatrics & adolescent medicine

相关期刊

检索历史清除